# A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.

> **NCT00369018** · PHASE1,PHASE2 · COMPLETED · sponsor: **Photocure** · enrollment: 96 (estimated)

## Conditions studied

- Cervical Dysplasia

## Interventions

- **DRUG:** methyl aminolevulinate (MAL) and hexaminolevulinate (HAL)

## Key facts

- **NCT ID:** NCT00369018
- **Lead sponsor:** Photocure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2010-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00369018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00369018, "A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00369018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*